交易 Ovid Therapeutics Inc. - OVID CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.07 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Ovid Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 27, 2024 | 3.02 | 0.04 | 1.34% | 2.98 | 3.08 | 2.91 |
Mar 26, 2024 | 2.97 | -0.07 | -2.30% | 3.04 | 3.18 | 2.97 |
Mar 25, 2024 | 3.07 | 0.03 | 0.99% | 3.04 | 3.23 | 2.98 |
Mar 22, 2024 | 3.17 | 0.14 | 4.62% | 3.03 | 3.35 | 3.03 |
Mar 21, 2024 | 3.03 | 0.14 | 4.84% | 2.89 | 3.14 | 2.89 |
Mar 20, 2024 | 2.77 | 0.09 | 3.36% | 2.68 | 2.82 | 2.61 |
Mar 19, 2024 | 2.71 | 0.00 | 0.00% | 2.71 | 2.74 | 2.68 |
Mar 18, 2024 | 2.69 | -0.02 | -0.74% | 2.71 | 2.73 | 2.65 |
Mar 15, 2024 | 2.68 | 0.00 | 0.00% | 2.68 | 2.92 | 2.61 |
Mar 14, 2024 | 2.70 | -0.13 | -4.59% | 2.83 | 2.84 | 2.69 |
Mar 13, 2024 | 2.77 | 0.05 | 1.84% | 2.72 | 2.83 | 2.68 |
Mar 12, 2024 | 2.78 | -0.10 | -3.47% | 2.88 | 3.00 | 2.77 |
Mar 11, 2024 | 2.92 | -0.06 | -2.01% | 2.98 | 3.04 | 2.90 |
Mar 8, 2024 | 3.06 | -0.03 | -0.97% | 3.09 | 3.18 | 3.05 |
Mar 7, 2024 | 3.14 | -0.07 | -2.18% | 3.21 | 3.21 | 3.13 |
Mar 6, 2024 | 3.21 | 0.03 | 0.94% | 3.18 | 3.24 | 3.18 |
Mar 5, 2024 | 3.24 | -0.04 | -1.22% | 3.28 | 3.32 | 3.19 |
Mar 4, 2024 | 3.31 | 0.04 | 1.22% | 3.27 | 3.34 | 3.21 |
Mar 1, 2024 | 3.37 | -0.01 | -0.30% | 3.38 | 3.40 | 3.27 |
Feb 29, 2024 | 3.38 | -0.07 | -2.03% | 3.45 | 3.49 | 3.28 |
Ovid Therapeutics Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Friday, May 3, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 Ovid Therapeutics Inc Earnings Release Q1 2024 Ovid Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, June 7, 2024 | ||
時間 (UTC) 17:00 | 國家 US
| 事件 Ovid Therapeutics Inc Annual Shareholders Meeting Ovid Therapeutics Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 1.50275 | 208.383 | 12.6172 | 0 | 0 |
收入 | 1.50275 | 208.383 | 12.6172 | 0 | 0 |
總營業費用 | 57.0509 | 84.1737 | 94.0482 | 61.4095 | 52.9317 |
銷售/一般/行政費用,總計 | 32.4325 | 37.2341 | 30.6308 | 19.2518 | 19.1416 |
研究與開發 | 24.6184 | 46.9396 | 63.4174 | 42.1576 | 33.79 |
營業收入 | -55.5482 | 124.209 | -81.431 | -61.4095 | -52.9317 |
利息收入(費用),非經營淨值 | 1.87913 | -0.04569 | 0.3954 | 0.94822 | 0.95207 |
稅前淨收入 | -54.169 | 124.163 | -81.0356 | -60.4612 | -51.9796 |
稅後淨收入 | -54.169 | 122.835 | -81.0356 | -60.4612 | -51.9796 |
未計算非常項目前的淨收益 | -54.169 | 122.835 | -81.0356 | -60.4612 | -51.9796 |
淨收入 | -54.169 | 122.835 | -81.0356 | -60.4612 | -51.9796 |
普通股股東可獲收益 (不含非經常性項目) | -54.169 | 119.839 | -81.0356 | -60.4612 | -51.9796 |
普通股股東可獲收益 (含非經常性項目) | -54.169 | 119.839 | -81.0356 | -60.4612 | -51.9796 |
攤薄調整 | |||||
攤薄淨收入 | -54.169 | 119.839 | -81.0356 | -60.4612 | -51.9796 |
攤薄後加權平均股 | 70.4248 | 68.068 | 58.4513 | 39.2172 | 24.631 |
扣除特別項目的每股攤薄盈利 | -0.76918 | 1.76058 | -1.38638 | -1.5417 | -2.11033 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常攤薄盈利 | -0.76918 | 1.76058 | -1.38638 | -1.5417 | -2.11033 |
非常規項目總計 | |||||
Total Adjustments to Net Income | -2.99532 | ||||
其他,淨值 | -0.5 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0.075 | 0.06616 | 0.04628 | 0.0111 | 0 |
收入 | 0.075 | 0.06616 | 0.04628 | 0.0111 | 0 |
總營業費用 | 14.247 | 14.9585 | 12.2192 | 12.815 | 14.3043 |
銷售/一般/行政費用,總計 | 8.24822 | 8.34375 | 6.66299 | 7.63171 | 8.25762 |
研究與開發 | 5.99877 | 6.61472 | 5.55621 | 5.18325 | 6.04667 |
營業收入 | -14.172 | -14.8923 | -12.1729 | -12.8039 | -14.3043 |
利息收入(費用),非經營淨值 | 1.36365 | 1.1361 | 1.06812 | 1.03609 | 0.31587 |
稅前淨收入 | -12.4083 | -13.3562 | -11.5048 | -11.9678 | -14.5884 |
稅後淨收入 | -12.4083 | -13.3562 | -11.5048 | -11.9678 | -14.5884 |
未計算非常項目前的淨收益 | -12.4083 | -13.3562 | -11.5048 | -11.9678 | -14.5884 |
淨收入 | -12.4083 | -13.3562 | -11.5048 | -11.9678 | -14.5884 |
Total Adjustments to Net Income | |||||
普通股股東可獲收益 (不含非經常性項目) | -12.4083 | -13.3562 | -11.5048 | -11.9678 | -14.5884 |
普通股股東可獲收益 (含非經常性項目) | -12.4083 | -13.3562 | -11.5048 | -11.9678 | -14.5884 |
攤薄淨收入 | -12.4083 | -13.3562 | -11.5048 | -11.9678 | -14.5884 |
攤薄後加權平均股 | 70.5342 | 70.4907 | 70.4733 | 70.4305 | 70.3915 |
扣除特別項目的每股攤薄盈利 | -0.17592 | -0.18947 | -0.16325 | -0.16992 | -0.20725 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.17592 | -0.18947 | -0.16325 | -0.16992 | -0.20725 |
Other Operating Expenses, Total | |||||
其他,淨值 | 0.4 | 0.4 | -0.4 | -0.2 | -0.6 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 131.381 | 190.479 | 74.8432 | 79.8132 | 44.2682 |
現金和短期投資 | 129.001 | 187.798 | 72.0339 | 76.7391 | 41.5006 |
現金等價物 | 42.0148 | 187.592 | 70.0566 | 41.3956 | 35.5623 |
應收賬款總額,淨額 | 0 | 0.14176 | 1.13115 | ||
預付的費用 | 2.37928 | 2.6816 | 2.66751 | 1.94293 | 2.7675 |
其他流動資産,總計 | |||||
總資産 | 155.266 | 194.545 | 75.9255 | 80.8437 | 47.6496 |
物業/廠房/設備,總計 - 淨額 | 16.0706 | 0.24276 | 0.13562 | 0.06836 | 0.06987 |
物業/廠房/設備,總計 - 總額 | 1.42303 | 0.50497 | 0.32096 | 0.19372 | 0.15603 |
累計折舊,總計 | -0.58138 | -0.26221 | -0.18534 | -0.12535 | -0.08616 |
其他長期資産,總計 | 1.96984 | 2.02688 | 0.6278 | 0.96218 | 3.31159 |
流動負債總額 | 6.99153 | 14.7983 | 22.0628 | 10.5336 | 8.84446 |
應付賬款 | 1.95291 | 7.12705 | 5.44621 | 3.2561 | 3.7556 |
預提費用 | 5.03862 | 7.67128 | 12.0327 | 7.26671 | 5.08886 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0 | 4.58388 | 0.0108 | ||
負債總額 | 22.9932 | 14.7983 | 32.2939 | 10.8202 | 8.84446 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 16.0017 | 0 | 10.2311 | 0.28656 | |
股權 | 132.273 | 179.746 | 43.6317 | 70.0236 | 38.8051 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0.00001 | 0 |
普通股 | 0.07047 | 0.07036 | 0.06574 | 0.05471 | 0.02465 |
額外實收資本 | 357.771 | 351.034 | 337.758 | 283.123 | 191.478 |
留存收益(累計赤字) | -225.527 | -171.358 | -294.192 | -213.157 | -152.695 |
總負債和股東權益 | 155.266 | 194.545 | 75.9255 | 80.8437 | 47.6496 |
已發行普通股總數 | 70.4669 | 70.3649 | 65.7432 | 54.7103 | 24.6541 |
Total Preferred Shares Outstanding | 0.00125 | 0.00125 | 0.00325 | 0.00776 | 0 |
現金 | 2.85304 | 0.20556 | 1.97732 | 0.50154 | 0.92735 |
短期投資 | 84.1336 | 0 | 34.842 | 5.01103 | |
其他權益,總計 | -0.04219 | 0 | 0.00247 | -0.00183 | |
應收賬款 - 貿易,淨額 | 0 | 0.14176 | 1.13115 | ||
無形資産,淨額 | 0.2221 | 0.164 | 0.3189 | ||
長期投資 | 5.62255 | 1.63199 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 91.7134 | 102.171 | 119.519 | 131.381 | 140.498 |
現金和短期投資 | 87.0717 | 96.5174 | 117.72 | 129.001 | 137.858 |
現金 | 0.80918 | 0.8686 | 2.34636 | 2.85304 | 1.74906 |
現金等價物 | 56.6274 | 70.7547 | 60.7056 | 42.0148 | 56.5081 |
應收賬款總額,淨額 | |||||
應收賬款 - 貿易,淨額 | |||||
預付的費用 | 4.64167 | 5.65347 | 1.79934 | 2.37928 | 2.64048 |
總資産 | 125.029 | 136.23 | 143.367 | 155.266 | 165.032 |
物業/廠房/設備,總計 - 淨額 | 15.0117 | 15.3676 | 15.7224 | 16.0706 | 16.3373 |
物業/廠房/設備,總計 - 總額 | 1.44963 | 1.44439 | 1.43659 | 1.42303 | 1.30309 |
累計折舊,總計 | -0.89946 | -0.79513 | -0.68984 | -0.58138 | -0.44975 |
無形資産,淨額 | 0.22205 | 0.26337 | 0.18591 | 0.2221 | 0.27545 |
其他長期資産,總計 | 1.95735 | 1.95735 | 1.95685 | 1.96984 | 1.96934 |
流動負債總額 | 8.66346 | 10.1415 | 6.721 | 6.99153 | 6.7323 |
應付賬款 | 1.21656 | 3.76329 | 1.83149 | 1.95291 | 1.03307 |
預提費用 | 7.44689 | 6.37823 | 4.88951 | 5.03862 | 5.4147 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0.28454 | ||||
負債總額 | 23.7367 | 25.5311 | 22.4193 | 22.9932 | 22.9811 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 15.0733 | 15.3896 | 15.6983 | 16.0017 | 16.2488 |
股權 | 101.292 | 110.699 | 120.948 | 132.273 | 142.051 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
普通股 | 0.07068 | 0.0706 | 0.07049 | 0.07047 | 0.07047 |
額外實收資本 | 363.769 | 361.914 | 359.754 | 357.771 | 356.085 |
留存收益(累計赤字) | -262.543 | -251.291 | -238.883 | -225.527 | -214.022 |
其他權益,總計 | -0.00388 | 0.00521 | 0.00563 | -0.04219 | -0.08279 |
總負債和股東權益 | 125.029 | 136.23 | 143.367 | 155.266 | 165.032 |
已發行普通股總數 | 70.6805 | 70.6028 | 70.4915 | 70.4669 | 70.4669 |
Total Preferred Shares Outstanding | 0.00125 | 0.00125 | 0.00125 | 0.00125 | 0.00125 |
長期投資 | 16.1242 | 16.4705 | 5.98245 | 5.62255 | 5.95164 |
短期投資 | 29.6351 | 24.8941 | 54.6681 | 84.1336 | 79.6005 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -54.169 | 122.835 | -81.0356 | -60.4612 | -51.9796 |
經營活動産生的現金 | -55.2271 | 118.612 | -51.5839 | -51.0906 | -45.5585 |
經營活動産生的現金 | 0.51251 | 0.23708 | 0.30685 | 0.255 | 0.14173 |
非現金物品 | 6.66085 | 12.3545 | 7.52535 | 5.20579 | 7.06855 |
營運資金的變化 | -8.23145 | -16.8144 | 21.6195 | 3.90983 | -0.78915 |
投資活動産生的現金 | -87.8832 | -1.8214 | 34.6482 | -30.041 | -5.36364 |
資本支出 | -1.41878 | -0.18941 | -0.39068 | -0.24405 | -0.35202 |
融資活動産生的現金 | 0.18066 | 0.90408 | 47.0725 | 86.5392 | 0.28614 |
融資現金流項目 | 0 | -0.02131 | -0.16325 | 0 | |
股票的發行(報廢),淨額 | 0.18066 | 0.9254 | 47.2357 | 86.5392 | 0.28614 |
現金淨變化 | -142.93 | 117.694 | 30.1368 | 5.40753 | -50.636 |
其他投資現金流量項目,總計 | -86.4644 | -1.63199 | 35.0389 | -29.797 | -5.01162 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -13.3562 | -54.169 | -42.6642 | -30.6965 | -16.1081 |
Cash From Operating Activities | -12.1123 | -55.2271 | -46.0514 | -33.375 | -20.0864 |
Cash From Operating Activities | 0.14465 | 0.51251 | 0.32753 | 0.17211 | 0.07381 |
Non-Cash Items | 1.3693 | 6.66085 | 4.45062 | 2.94724 | 0.26067 |
Changes in Working Capital | -0.27 | -8.23145 | -8.1653 | -5.79789 | -4.31284 |
Cash From Investing Activities | 30.2288 | -87.8832 | -83.7137 | -81.7534 | -1.07617 |
Capital Expenditures | -0.01356 | -1.41878 | -1.35578 | -1.33718 | -0.07617 |
Other Investing Cash Flow Items, Total | 30.2424 | -86.4644 | -82.3579 | -80.4162 | -1 |
Cash From Financing Activities | 0.06699 | 0.18066 | 0.22426 | 0.14263 | 0.03308 |
Financing Cash Flow Items | 0 | 0 | 0 | 0 | |
Issuance (Retirement) of Stock, Net | 0.06699 | 0.18066 | 0.22426 | 0.14263 | 0.03308 |
Net Change in Cash | 18.1836 | -142.93 | -129.541 | -114.986 | -21.1295 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
441 Ninth Avenue, 14Th Floor
NEW YORK
NEW YORK 10001
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易